PD-L1-IN-2 - Search Results | AbMole BioScience

About 6 results found for searched term "PD-L1-IN-2" (0.052 seconds)

Cat.No.	Name	Target
M5144	BMS202	PD-1/PD-L1
	PD-1/PD-L1 inhibitor 2
	Bms-202 is an effective non-peptide PD-1/PD-L complex inhibitor with IC50 of 18 nM and KD of 8 μM. Bms-202 directly binds to PD-L1 and blocks the human PD-1/PD-L interaction. Bms-202 has antitumor activity.
M11456	Evixapodlin	PD-1/PD-L1
	PD-1/PD-L1-IN 7; GS-4224
	Evixapodlin (PD-1/ PD-L1-in 7) is an inhibitor of human PD-1/PD-L1 protein/protein interaction with an IC50 of 0.213 nM. Evixapodlin has anti-cancer and anti-virus properties.
M22489	Recombinant Human PD-L1 Protein (HEK293, C-His)	Cytokines and Growth Factors
	Programmed cell death 1 ligand 1
	Programmed cell death 1 ligand 1 (PD-L1) is also known as cluster of differentiation (CD274) or B7 homolog 1 (B7-H1), is a member of the growing B7 family of immune molecules and is involved in the regulation of cellular and humoral immune responses.
M24961	PD-1/PD-L1-IN-20	PD-1/PD-L1
	PD-1/PD-L1-IN-20 (Example 21) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-20 blocks PD-1/PD-L1 with the IC50 of 5.29 nM. PD-1/PD-L1-IN-20 can be used for the research of cancers, infectious diseases and autoimmune diseases.
M42030	PD-1/PD-L1-IN-32	PD-1/PD-L1
	PD-1/PD-L1-IN-32 is a potent PD-1/PD-L1 inhibitor (IC50=2.4 nM), with anticancer activity.
M42031	PD-L1-IN-2	PD-1/PD-L1
	PD-L1-IN-2 is a potential tumor immunological agent by inhibiting PD-L1.